Malignant glioma: Genetics and biology of a grave matter

Genes and Development

Volumn 15, Issue 11, 2001, Pages 1311-1333

  Maher, Elizabeth A ^a   Furnari, Frank B ^d   Bachoo, Robert M ^a,b   Rowitch, David H ^a   Louis, David N ^b   Cavenee, Webster K ^d,e   DePinho, Ronald A ^a,c  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; EPIDERMAL GROWTH FACTOR RECEPTOR; GLIAL FIBRILLARY ACIDIC PROTEIN; PLATELET DERIVED GROWTH FACTOR; PROTEIN P53; RETINOBLASTOMA PROTEIN;

ANIMAL MODEL; ASTROCYTOMA; BRAIN TUMOR; CANCER GRADING; CENTRAL NERVOUS SYSTEM TUMOR; CHROMOSOME 10Q; GENE MUTATION; GLIOBLASTOMA; GLIOMA; HISTOPATHOLOGY; HUMAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; TUMOR SUPPRESSOR GENE;

ANIMALS; CELL DIFFERENTIATION; CYCLIN-DEPENDENT KINASES; DISEASE MODELS, ANIMAL; GENES, P53; GENES, RETINOBLASTOMA; GENES, TUMOR SUPPRESSOR; GLIOMA; GROWTH SUBSTANCES; HUMANS; MICE; NEOVASCULARIZATION, PATHOLOGIC;

ANIMALIA;

EID: 0034987702     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.891601     Document Type: Review

References (217)

1. Neural stem cells display extensive tropism for pathology in adult brain: Evidence from intracranial gliomas
2. Terminal differentiation in epithelia: The Hensin pathway in intercalated cells
3. Functional analysis of wild-type and malignant glioma derived CDKN2Aβ alleles: Evidence for an RB-independent growth suppressive pathway
4. Regulation of mdm2 expression by p53: Alternative promoters produce transcripts with nonidentical translation potential
5. Glioblastoma cells do not intravasate into blood vessels
6. Identical mutations of the p53 tumor supressor gene in the gliomatous and the sarcomatous components of gliosarcomas suggest a common origin from glial cells
7. Characterization of the epidermal growth factor receptor in human glioma cell lines and xenografts
8. Intracellular signaling pathways required for rat vascular smooth muscle cell migration. Interactions between basic fibroblast growth factor and platelet-derived growth factor
9. Turning brain into blood: A hematopoietic fate adopted by adult neural stem cells in vivo
10. Radiation therapy in the management of neoplasms of the central nervous system, with a special note in regard to children: Twenty years experience
11. Molecular genetic alterations in radiation-induced astrocytomas
12. Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation
13. Chemotaxis of rat brain astrocytes to platelet derived growth factor
14. Chromosomal mapping of members of the cdc2 family of protein kinases, cdk3, cdk6, PISSLRE, and PITALRE, and a cdk inhibitor, p27Kip1, to regions involved in human cancer
15. Response diversity and the timing of progenitor cell maturation are regulated by developmental changes in EGFR expression in the cortex
16. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas
17. Oligodendrocyte population dynamics and the role of PDGF in vivo
18. Role of tissue factor in embryonic blood vessel development
19. Suppression of tumorigenicity of glioblastoma cells by adenovirus-mediated MMAC1/PTEN gene transfer
20. Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factor
21. Stem cell repopulation efficiency but not pool size is governed by p27kip1
22. TP53 gene mutations and 17p deletions in human astrocytomas
23. Platelet-derived growth factor receptor signals
24. Generalized potential of adult neural stem cells
25. Silencing of p16/CDKN2 expression in human gliomas by methylation and chromatin condensation
26. Cyclin-dependent kinase 6 (CDK6) amplification in human gliomas identified using two-dimensional separation of genomic DNA
27. In vivo growth factor expansion of endogenous subependymal neural precursor cell populations in the adult mouse brain
28. Sonic hedgehog regulates the growth and patterning of the cerebellum
29. Chromosomal mapping of human CDK2, CDK4, and CDK5 cell cycle kinase genes
30. Pten is essential for embryonic development and tumour suppression
31. p27Kip1 alters the response of cells to mitogen and is part of a cell-intrinsic timer that arrests the cell cycle and initiates differentiation
32. Mapping of two genes encoding members of a distinct subfamily of MAX interacting proteins: MAD to human chromosome 2 and mouse chromosome 6, and MXI1 to human chromosome 10 and mouse chromosome 19
33. Genes for epidermal growth factor receptor, transforming growth factor α, and epidermal growth factor and their expression in human gliomas in vivo
34. Cell scattering and migration induced by autocrine transforming growth factor α in human glioma cells in vitro
35. PTEN and inherited hamartoma-cancer syndromes
36. The chemotactic and mitogenic effects of platelet-derived growth factor-BB on rat aorta smooth muscle cells are inhibited by basic fibroblast growth factor
37. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
38. Comparing astrocytic cell lines that are inhinitory of permissive for axon growth: The major axon-inhibitory proteoglycan is NG2
39. Phase II trial of the antiangiogenic agent thalidomide in patients with recurrent high-grade gliomas
40. Platelet-derived growth factor induces chemotaxis of neuroepithelial stem cells
41. EGF infusion stimulates the proliferation and migration of embryonic progenitor cells transplanted in the adult rat striatum
42. Deletion mapping of the long arm of chromosome 10 in glioblastoma multiforme
43. Allelotype of human malignant astrocytoma
44. Growth suppression of glioma cells by PTEN requires a funcional phosphatase catalytic domain
45. The phosphoinositol phosphatase activity of PTEN mediates a serumsensitive G1 growth arrest in glioma cells
46. p27Kip1 expression by contact inhibition as a prognostic index of human glioma
47. Skeletal myogenic potential of human and mouse neural stem cells
48. Cell and molecular analysis of the developing and adult mouse subventricular zone of the cerebral hemispheres
49. Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: A model of glioblastoma multiforme pathophysiology
50. Expression of developmentally defined retinal phenotypes in the histogenesis of retinoblastoma
51. The Myc/Max/Mad network and the transcriptional control of cell behavior
52. Proliferation of human malignant astrocytomas is dependent on Ras activation
53. Splicing into senescence: The curious case of p16 and p19ARF
54. Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome
55. Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer
56. Riding the glial monorail: A common mechanism for glial-guided neuronal migration in different regions of the developing mammalian brain
57. Central nervous system neuronal migration
58. Mdm2 promotes the rapid degradation of p53
59. Protein tyrosine kinase receptors
60. Platelet-derived growth factor: Mechanism of action and possible in vivo function
61. The retinoblastoma gene is involved in malignant progression of astrocytomas
62. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers
63. Platelet-derived growth factor and its receptors in human glioma tissue: Expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops
64. Association of loss of heterozygosity on chromosome 17p with high platelet-derived growth factor α receptor expression in human malignant gliomas
65. A constitutively active epidermal growth factor receptor cooperates with disruption of G1 cell-cycle arrest pathways to induce glioma-like lesions in mice
66. Modeling mutations in the G1 arrest pathway in human gliomas: Overexpression of CDK4 but not loss of INK4a-ARF induces hyperploidy in cultured mouse astrocytes
67. Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice
68. Gene expression profiling of low-grade diffuse astrocytomas by cDNA arrays
69. Anti-synthetic peptide antibody reacting at the fusion junction of deletion-mutant epidermal growth factor receptors in human glioblastoma
70. Radial glial cell transformation to astrocytes is bidirectional regulation by a diffusible factor in embryonic forebrain
71. Distinct patterns of deletion on 10p and 10q suggest involvement of multiple tumor suppressor genes in the development of astrocytic gliomas of different malignancy grades
72. Molecular subtypes of anaplastic oligodendroglioma: Implications for patient management at diagnosis
73. MdmX protects p53 from Mdm2-mediated degradation
74. Clonal genomic alterations in glioma malignancy stages
75. Chromosome 9 deletion mapping reveals interferon α and interferon β-1 gene deletions in human glial tumors
76. Identification of a neural stem cell in the adult mammalian central nervous system
77. Human homolog of patched, a candidate gene for the basal cell nevus syndrome
78. Patterns and dynamics of SVZ cell migration in the postnatal forebrain: Monitoring living progenitors in slice preparations
79. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF
80. Tumor spectrum in ARF-deficient mice
81. Historical perspective
82. Shared allelic losses on chromosomes 1p and 19q suggest a commoon origin of oligodendroglioma and oligoastrocytoma
83. Regulation of p53 stability by Mdm2
84. Elevated levels of urokinase-type plasminogen activator and plasminogen activator inhibitor type-1 in malignant human brain tumors
85. Pathways leading to glioblastoma multiforme: A molecular analysis of genetic alterations in 65 astrocytic tumors
86. Mature astrocytes transform into transitional radial glia within adult mouse neocortex that supports directed migration of transplanted immature neurons
87. p27(Kip1) regulates cell cycle withdrawal of late multipotent progenitor cells in the mammalian retina
88. The migrational patterns and developmental fates of glial precursors in the rat subventricular zone are temporally regulated
89. PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells
90. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer
91. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome
92. Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin
93. Allelic deletion analyses of MMAC/PTEN and DMBT1 loci in gliomas: Relationship to prognostic significance
94. Neurogenesis and gliogenesis in the postischemic brain
95. The p53 gene and protein in human brain tumors
96. Molecular biology of central nervous system neoplasms
97. Molecular biology of central nervous system tumors
98. TGF α deficiency results in hair follicle and eye abnormalities in targeted and waved-1 mice
99. The mouse waved-2 phenotype results from a point mutation in the EGF receptor tyrosine kinase
100. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate
101. Induction of neurogenesis in the neocortex of adult mice
102. Molecular genetic evidence for subtypes of oligoastrocytomas
103. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms
104. Secretion of cathepsin B by human gliomas in vitro
105. Patterns of antigenic expression of human glioma cells
106. FGF modulates the PDGF-driven pathway of oligodendrocyte development
107. Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor
108. A cell cycle alteration precedes apoptosis of granule cell precursors in the weaver mouse cerebellum
109. Biology and biochemistry of proteinases in tumor invasion
110. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant
111. Contrasting effects of mitogenic growth factors on oligodendrocyte precursor cell migration
112. Expression of a specific mutant epidermal growth factor receptor mediates glioma cell invasion in vivo
113. Mapping of gene loci in the Q13-Q15 region of chromosome 12
114. A role for p27/Kip1 in the control of cerebellar granule cell precursor proliferation
115. DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3-26.1 is deleted in malignant brain tumours
116. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation
117. Clonal analysis in glioblastoma with epithelial differentation
118. A common neural progenitor for the CNS and PNS
119. P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase
120. The lipid phosphatase activity of PTEN is critical for its tumor supressor function
121. A common mutant epidermal growth factor receptor confers enhanced tumorigenicity on human glioblastoma cells by increasing proliferation and reducing apoptosis
122. Drug resistance of human glioblastoma cells conferred by a tumor-specific mutant epidermal growth factor receptor through modulation of Bcl-XL and caspase-3-like proteases
123. Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors
124. Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors
125. Cell proliferation and nestin expression in the ependyma of the adult rat spinal cord after injury
126. Second neoplasms after acute lymphoblastic leukemia in childhood
127. A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity
128. Loss of P16INK4 expression is frequent in high grade gliomas
129. Molecular analysis of deletions of the short arm of chromosome 9 in human gliomas
130. Developmental expression of platelet-derived growth factor-receptor in neurons and glial cells of the mouse CNS
131. The adult rat hippocampus contains primordial neural stem cells
132. Tumor-selective transgene expression in vivo mediated by an E2F responsive adenoviral vector
133. The p53-mdm2 autoregulatory feedback loop: A paradigm for the regulation of growth control by p53?
134. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo
135. EHD2, EHD3, and EHD4 encode novel members of a highly conserved family of EH domain-containing proteins
136. The Ink4a tumor suppressor gene product, p 19arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53
137. PDGF receptors in the rat CNS: During late neurogenesis, PDGF α-receptor expression appears to be restricted to glial cells of the oligodendrocyte lineage
138. Cloning and characterization of murine p16INK4a and p15INK4b genes
139. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest
140. Sequential expression of the MAD family of transcriptional repressors during differentiation and development
141. Sporadic medulloblastomas contain PTCH mutations
142. Mode of cell migration to the superficial layers of fetal monkey neocortex
143. A germline deletion of p14(ARF) but not CDKN2A in a melanoma-neural system tumour syndrome family
144. Cytogenetic and loss of heterozygosity studies in ependymomas, pilocytic astrocytomas, and oligodendrogliomas
145. Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations
146. Amplification of multiple genes from chromosomal region 12q13-q14 in human malignant gliomas: Preliminary mapping of the amplicons shows preferential involvement of CDK4, SAS, and MDM2
147. Oligodendrogliomas and oligoastrocytomas
148. Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects
149. Generation of neurons and astrocytes from isolated cells in the central nervous system
150. Clonal and population analyses demonstrate that an EGF-responsive mammalian embryonic CNS precursor is a stem cell
151. Tumors of the brain and nervous system after radiotherapy in childhood
152. Identification, isolation, and promoter-defined separation of mitotic oligodendrocyte progenitor cells from the adult human subcortical white matter
153. Analysis of the neurofibromatosis 2 gene in human ependymomas and astrocytomas
154. Differential expression of MMAC/PTEN in glioblastoma multiforme: Relationship to localization and prognosis
155. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation
156. The forms of growth in gliomas and their practical signficance
157. CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas
158. Repression by the Mad(Mxi1)-Sin3 complex
159. Role of Mxi1 in ageing organ systems and the regulation of normal and neoplastic growth
160. Identification of A2B5-positive putative oligodendrocyte progenitor cells and A2B5-positive astrocytes in adult human white matter
161. Role of the INK4a locus in tumor suppression and cell mortality
162. Failure of bloodisland formation and vasculogenesis in Flk-1-deficient mice
163. Randomized trial of three chemotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma
164. Cancer cell cycles
165. The Pezcoller lecture: Cancer cell cycles revisited
166. Expression of oligodendrocyte progenitor cell antigens by gliomas: Implications for the histogenesis of brain tumors
167. A strain-independent postnatal neurodegeneration in mice lacking the EGF receptor
168. Clonal expansion of p53 mutant cells is associated with brain tumour progression
169. Intracellular signals and cytoskeletal elements involved in oligodendrocyte progenitor migration
170. Glial cell lineages in development and disease
171. A transcript map of the chromosome 19 q-arm tumor supressor region
172. Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition
173. Cajal-Retzius cells regulate the radial glia phenotype in the adult and developing cerebellum and alter granule cell migration
174. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN
175. Identification of a candidate tumour suppressor gene, MMAC 1, at chromosome 10q23.3 that is mutated in multiple advanced cancers
176. The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2
177. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis
178. Proliferation of neuronal precursor cells in the dentate gyrus is accelerated after transient forebrain ischemia in mice
179. Hensin, the polarity reversal protein, is encoded by DMBT1, a gene frequently deleted in malignant gliomas
180. Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN
181. MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines
182. Targeted disruption of mouse EGF receptor: Effect of genetic background on mutant phenotype
183. Ectopic expression of p27Kip1 in oligodendrocyte progenitor cells results in cell-cycle growth arrest
184. Cell contact regulates fate choice by cortical stem cells
185. CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated
186. Mechanisms of glioma invasion: Role of matrix-metalloproteinases
187. Dependence of autocrine growth factor stimulation in platelet-derived growth factor-B-induced mouse brain tumor cells
188. Phosphorylation of the PTEN tail regulates protein stability and function
189. Development of glial cells in the cerebral wall of ferrets: Direct tracing of their transformation from radial glia into astrocytes
190. p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma
191. Association of epidermal growth factor receptor gene amplification with loss of chromosome 10 in human glioblastoma multiforme
192. Subsets of glioblastoma mulitforme defined by molecular genetic analysis
193. Loci associated with malignant progression in astrocytomas: A candidate on chromosome 19q
194. Purkinje-cell-derived Sonic hedgehog regulates granule neuron precursor cell proliferation in the developing mouse cerebellum
195. Somatic mutations of PTEN in glioblastoma multiforme
196. Ras-stimulated extracellular signal-related kinase 1 and RhoA activities coordinate platelet-derived growth factor-induced G1 progression through the independent regulation of cyclin D1 and p27
197. MXI1, a putative tumor suppressor gene, suppresses growth of human glioblastoma cells
198. Control of neuronal precursor proliferation in the cerebellum by Sonic hedgehog
199. Striatal TGF-α: Postnatal developmental expression and evidence for a role in the proliferation of subependymal cells
200. Increased proliferation of precursor cells in the adult rat brain after targeted lesioning
201. Development and malignant progression of astrocytomas in GFAP-v-src transgenic mice
202. Inhibition of phosphatidylinositol 3-kinase and protein kinase C attenuates extracellular matrix protein-induced vascular smooth muscle cell chemotaxis
203. Platelet-derived growth factor is mitogenic for O-2A adult progenitor cells
204. Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification
205. Structual alterations of the epidermal growth factor receptor gene in human gliomas
206. The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway
207. Expression and localization of urokinase-type plasminogen activator receptor in human gliomas
208. Epidermal growth factor induces rapid, reversible aggregation of the purified epidermal growth factor receptor
209. PDGF A-chain gene is expressed by mammalian neurons during development and in maturity
210. Developmental expression of the platelet-derived growth factor α-receptor gene in mammalian central nervous system
211. Cloning of a highly conserved human protein serine-threonine phosphatase gene from the glioma candidate region on chromosome 19q13.3
212. Vascular apoptosis and involution in gliomas precede neovascularization: A novel concept for glioma growth and angiogenesis
213. A functional p53-responsive intronic promoter is contained within the human mdm2 gene
214. Adult brain retains the potential to generate oligodendroglial progenitors with extensive myelination capacity
215. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways
216. Developmental changes in progenitor cell responsiveness to cytokines